Evidence map›Paper›PMID 40617883›Full record

ArticleScientific reports2025

The association between altitude and cerebral small vessel disease burden in the Tibetan population: a cross-sectional study.

Shaoli Yao, Zhen-Rong Qi, Shi-Min Bao, Yi-Yin Xing, Hui-Ru Feng, Yuling Tan, Qi Zhang, Wei-Hong Ge, Xiaorong Chen

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shaoli Yao *Department of Neurology, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, No. 20, Ximianqiao Street, Chengdu, 610041, Sichuan, China. 15208354834@163.com.
Zhen-Rong Qi *Department of Neurology, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, No. 20, Ximianqiao Street, Chengdu, 610041, Sichuan, China.
Shi-Min BaoDepartment of Neurology, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, No. 20, Ximianqiao Street, Chengdu, 610041, Sichuan, China.
Yi-Yin XingDepartment of Neurology, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, No. 20, Ximianqiao Street, Chengdu, 610041, Sichuan, China.
Hui-Ru FengDepartment of Neurology, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, No. 20, Ximianqiao Street, Chengdu, 610041, Sichuan, China.
Yuling TanDepartment of Neurology, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, No. 20, Ximianqiao Street, Chengdu, 610041, Sichuan, China.
Qi ZhangDepartment of Neurology, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, No. 20, Ximianqiao Street, Chengdu, 610041, Sichuan, China.
Wei-Hong GeDepartment of Neurology, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, No. 20, Ximianqiao Street, Chengdu, 610041, Sichuan, China.
Xiaorong ChenDepartment of Neurology, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, No. 20, Ximianqiao Street, Chengdu, 610041, Sichuan, China.

Funding

the hospital-level research project of the Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region Chengdu, China 2022-YJ-3
6 · The paper itself

Abstract

Cerebral small vessel disease (CSVD) is a major neurovascular contributor to stroke and cognitive impairment, yet its interaction with chronic high-altitude adaptation remains poorly understood. This first neuroimaging investigation examined 499 Tibetan natives residing at 2000-4800 m using 3 T MRI to quantify CSVD burden and to assess its association with residential altitude. Multivariable logistic regression, treating altitude as both a continuous variable (per 500 m increment) and a categorical variable (mid-high [2000-3500 m] vs. ultra-high [> 3500 m]), revealed that 51.5% of participants had CSVD (CSVD score ≥ 1), with adjusted odds ratios of 0.94 (95% CI: 0.74-1.21) per 500 m altitude and 0.78 (95% CI: 0.42-1.44) for ultra-high versus mid-high altitude. Partial proportional odds model showed no significant association between altitude and CSVD score (OR = 1.18, 95% CI 0.99-1.40). These null findings, in contrast to the well-established paradoxical impact of altitude on stroke risk, suggest potential neuroprotective mechanisms in altitude-adapted populations. Our results challenge conventional cerebrovascular paradigms and highlight the need for further research into Tibetan-specific genetic adaptations that may modulate CSVD pathophysiology. This study provides essential insights for refining altitude-related cerebrovascular risk models.

Indexed as

AltitudeCerebral Small Vessel DiseasesAdultAgedCross-Sectional StudiesFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedRisk FactorsTibetAltitudeCSVD burdenHigh-altitude adaptationHypoxic exposureMRI biomarkersObservational studyTibetan Plateau

Identifiers

PMID40617883
PMCPMC12228771

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.